Who invested in Manus Bio

2 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcarePharma

Funding summaryUpdated 26 Oct 2026

$52Mraised across 2 rounds since 2018, from 2 sources

$19MSeries A$32MGrant

Latest round: Grant, $32MNov 2024
Step-upi: 1.7×
Investors: 2

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

201920202021202220232024

$19MSeries A$32MGrant

First round: Series A, $19M
Biggest round: $32M
Between rounds: 6.3 years

The rounds

Nov 2024
Grant$32M2 new
- National Science Foundation
- Alumni Ventures
Source recorded
Jul 2018
Series A$19M
No investor was named in the report.
Reported by FinSMEsSEC filing: $10M sold, first sale Jun 2018

Founders and team

From Manus Bio's own website and the SEC filings it signed: 1 founder, 10 on the team.

Ajikumar Parayil KumaranDr. Parayil is the Founder, President, and Chief Executive Officer of the Issuer.Named on its 2024 Form Di

Francisco De AubeyzonVice President, Operations
Frederik BjoerndalSenior Vice President, Corporate Affairs and Marketing
Gary DempseyVice President, Global Sales
Hsien-Chung TsengVice President, Business Operations
Joe ShawSenior Vice President, Research and Development
Rob EvansVice President, Business Development
Baljit Singh GhotraChief Operating Officer
Christine SantosChief Technology Officer
Julio A. Ruiz CalderonChief Financial Officer
Martyna PawlukDirector, Quality and Regulatory Affairs

On the board, as filediAlena A. IvashenkaJean A. NehmeMichael A. CarlosRick A. Gerson

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series A2018Grant2024

National Science Foundation

Alumni Ventures

Everyone who backed them

National Science FoundationGovernment1round

Alumni VenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 6 firms list Manus Bio as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.